Cutaneous T cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 54: | Line 54: | ||
* {{DermNet|dermal-infiltrative/cutaneous-t-cell-lymphoma}} | * {{DermNet|dermal-infiltrative/cutaneous-t-cell-lymphoma}} | ||
* [http://www.lymphoma.org/ Lymphoma Research Foundation] | * [http://www.lymphoma.org/ Lymphoma Research Foundation] | ||
* [http://www.clinicaltrials.gov/ct/show/NCT00106431 NCI Clinical Trial using Depsipeptide to treat CTCL] | * [http://www.clinicaltrials.gov/ct/show/NCT00106431 NCI Clinical Trial using Depsipeptide to treat CTCL] | ||
Revision as of 20:05, 11 September 2012
Template:DiseaseDisorder infobox For patient information, click here
|
Cutaneous T cell lymphoma Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cutaneous T cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Cost-Effectiveness of Therapy | Future or Investigational Therapies